🇺🇸 FDA
Pipeline program

BEP(500)

ICR-CTSU/2008/10019

Phase 3 small_molecule completed

Quick answer

BEP(500) for Stage I Testicular Non-Seminomatous Germ Cell Tumor is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Stage I Testicular Non-Seminomatous Germ Cell Tumor
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials